|
Academic research addressing the diagnosis and treatment of sexual dysfunction, hormone therapy and its effects on sexuality, addressing the needs of LGBTQ patients, and other sexuality issues.
The clinical research featured below encompasses the most recent developments in reproductive health. To learn more on how to best read and interpret the findings from clinical research, see In Brief: Interpreting Research Studies from the Guttmacher Institute.
-
Bray PF, Larson JC, Lacroix AZ, et al. Usefulness
of baseline lipids and C-reactive protein
in women receiving menopausal hormone therapy
as predictors of treatment-related coronary
events. Am J Cardiol. 2008 Jun
1;101(11):1599-1605.
-
Chlebowski RT, Anderson G, Pettinger M, et
al. Estrogen
Plus Progestin and Breast Cancer Detection
by Means of Mammography and Breast Biopsy.Arch
Intern Med. 2008;168(4):370-377.
-
Frank J, Mistretta P, and Will J. Diagnosis
and Treatment of Female Sexual Dysfunction.
American Family Physician. 2008 March;77(5):635-642.
-
Heiss G, Wallace R, Anderson GL et al. Health
Risks and Benefits 3 Years After Stopping
Randomized Treatment With Estrogen and Progestin.
JAMA. 2008;299(9):1036-1045.
-
Løkkegaard E, et al. Hormone
therapy and risk of myocardial infarction
in a national register study. Eur
Heart J 2008.
-
Nelson DB et al. Effect
of Physical Activity on Menopausal Symptoms
among Urban Women. Med Sci Sports
Exerc. 2008 Jan;40(1):50-8.
-
Nurnberg HG, Hensley PL, Heiman JR, Croft
HA, Debattista C and Paine S. Sildenafil
Treatment of Women With Antidepressant-Associated
Sexual Dysfunction: A Randomized Controlled
Trial. JAMA. 2008;300(4):395-404.
-
Rohan TE et al. Conjugated
Equine Estrogen and Risk of Benign Proliferative
Breast Disease: A Randomized Controlled Trial.
J Natl Cancer Inst. 2008 Apr 8.
-
Rosenberg LU, Granath F, Dickman PW, et al.
Menopausal
hormone therapy in relation to breast cancer
characteristics and prognosis: a cohort study.
Breast Cancer Res. 2008 Sep 19; 10(5):
R78.
-
Sare GM, Gray LJ, Bath PM. Association
between hormone replacement therapy and subsequent
arterial and venous vascular events: a meta-analysis.
Eur Heart J. 2008 Jul 3.
-
Welton AJ, Vickers MR, Kim J, Ford D, Lawton
BA, Maclennan AH, et al. for the WISDOM team.
Health
related quality of life after combined hormone
replacement therapy: randomised controlled
trial. BMJ. 2008 Aug 21;337.
-
West SL, D'Aloisio AA, Agans RP, Kalsbeek
WD, Borisov NN, Thorp JM. Prevalence
of low sexual desire and hypoactive sexual
desire disorder in a nationally representative
sample of US women. Arch Intern Med.
2008 Jul 14;168(13):1441-9.
For materials and resources for your patients, please visit the Consumer Information page.
Back to top | Back to Health Care Provider Index
|
